The price of long COVID: What the undiagnosed illness is costing employers

Published 4 Min Read

Polina Tankilevitch from Pexels

Long COVID can be a debilitating and life-altering repercussion of COVID-19. But between its relative newness and wide array of symptoms, it can be hard for patients and healthcare providers alike to identify it. 

The CDC estimates that 19% of Americans have symptoms of long COVID, while research group the Brookings Institution found that long COVID may be keeping four million Americans out of work. Yet, when health data analytics company Springbuk analyzed hundreds of thousands of employee health claims, only 1.8% had a long COVID diagnosis. 

Deanna Cuadra
Senior Reporter

Deanna Cuadra is a senior reporter at Employee Benefit News. Her work covers healthcare, U.S. policy and reform, challenges faced by women and parents in the workplace and innovation in work culture … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form